COVID-19 and hypercoagulability in the outpatient setting

Rothan, 2020, The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak, J. Autoimmun., 109, 102433, 10.1016/j.jaut.2020.102433

Gandhi, 2020, Mild or moderate COVID-19, N. Engl. J. Med., 10.1056/NEJMcp2009249

Bompard, 2020, Pulmonary embolism in patients with COVID-19 pneumonia, Eur. Respir. J., 2001365

Cui, 2020, Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia, J. Thromb. Haemost., 10.1111/jth.14830

Panigada, 2020, Hypercoagulability of COVID-19 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis, J. Thromb. Haemost., 10.1111/jth.14850

Zhang, 2020, Coagulopathy and antiphospholipid antibodies in patients with COVID-19, N. Engl. J. Med., 382, e38, 10.1056/NEJMc2007575

Tang, 2020, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, J. Thromb. Haemost., 18, 844, 10.1111/jth.14768

Lodigiani, 2020, Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy, Thromb. Res., 191, 9, 10.1016/j.thromres.2020.04.024

Wang, 2020, Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia, J. Infect. Dis., 10.1093/infdis/jiaa150

Matos, 2011, The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6-174GC, IL-8-251AT and MCP-1-2518AG in the risk of venous thromboembolism: a case-control study, Thromb. Res., 128, 216, 10.1016/j.thromres.2011.04.016

Spencer, 2007, Venous thromboembolism in the outpatient setting, Arch. Intern. Med., 167, 1471, 10.1001/archinte.167.14.1471

Connors, 2020, Thromboinflammation and the hypercoagulability of COVID-19, J. Thromb. Haemost., 10.1111/jth.14849

Wong, 2003, Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis, Br. Med. J., 326, 1358, 10.1136/bmj.326.7403.1358

Connors

Terpos, 2020, Hematological findings and complications of COVID-19, Am. J. Hematol., 10.1002/ajh.25829

Bikdeli, 2020, COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up, J. Am. Coll. Cardiol., 10.1016/j.jacc.2020.04.031

Barbar, 2010, A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score, J. Thromb. Haemost., 8, 2450, 10.1111/j.1538-7836.2010.04044.x

Wichmann, 2020, Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study, Ann. Intern. Med., 10.7326/M20-2003